C

Cergentis B.V.

38 employees

Cergentis provides services and kits based on its proprietary 'Targeted Locus Amplification' (TLA) technology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
genetic stability analysis
gene fusion detection
Complete Gene Sequencing
gene therapy
transgene sequencing
next generation sequencing
integration site sequencing
CHO cells
atmp
cell therapy
cell line characterization
genetic quality control
genetic engineering
transgenic animal models
quality control
Targeted Gene Sequencing
Translocation detection
solutions provider
Genetics
Medical
clonality assurance

Date founded

2012

Funding rounds raised

Total raised

$2.3M

from 1 investors over 1 rounds

C

Cergentis B.V. raised $2.3M on May 1, 2018

Investors: Executive Agency for Small and Medium-sized Enterprises (EASME)

FAQ